{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T06:56:05Z","timestamp":1794466565686,"version":"4.9.1"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:00:00Z","timestamp":1706140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>IgA vasculitis (IgAV) in adults has been relatively under-investigated. Since outcomes are worse in other forms of vasculitis with increasing age, we investigated the outcomes of IgAV comparing younger adults (18\u201334), middle-aged adults (35\u201364) and elderly patients (\u226564\u2009years) focusing on kidney outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We identified patients with renal biopsy-confirmed IgAV nephritis and collected data regarding clinical features and progression to end stage kidney disease (ESKD). The relationship between patient factors and ESKD was analysed by regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified 202 cases, 34% aged 18\u201334, 43% aged 35\u201364 and 23% elderly (&amp;gt;64\u2009years). Median follow-up was 44\u2009months. Elderly patients were more likely to present with ESKD (23.9%) compared with middle-aged (13.7%) and younger adults (2.9%) (\u03c72 11.6, P\u2009=\u20090.002). In patients with independent kidney function at biopsy, there was no difference in outcomes between age groups. Male gender, Black ethnicity, diabetes, histological evidence of chronic renal damage and estimated glomerular filtration rate\u2009&amp;lt;\u200930\u2009ml\/min were risk factors for development of ESKD. In this observational study 68.3% of patients received glucocorticoids and 56.9% additional immunosuppression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Elderly patients with IgAV are more likely to have ESKD at presentation, but there is no difference in renal survival between age groups, among those presenting with independent renal function. Renal impairment at biopsy is an independent risk factor for subsequent development of ESKD. There is significant variability in the timing of kidney biopsy and management of these patients among specialist centres. Young adults have outcomes more in keeping with childhood IgAV.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae030","type":"journal-article","created":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T07:33:09Z","timestamp":1705995189000},"page":"690-696","source":"Crossref","is-referenced-by-count":20,"title":["IgA vasculitis nephritis\u2014outcomes in adult-onset disease"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2532-2965","authenticated-orcid":false,"given":"James","family":"Stanway","sequence":"first","affiliation":[{"name":"UCL Centre for Nephrology, Royal Free Hospital , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Brown","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Salford Royal Foundation Trust , Salford,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afeera","family":"Pervez","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Queen Elizabeth Hospital , Birmingham,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Els","family":"Van de Perre","sequence":"additional","affiliation":[{"name":"Vasculitis Clinic, Addenbrooke\u2019s Hospital , Cambridge,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9825-701X","authenticated-orcid":false,"given":"James","family":"Tollitt","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Salford Royal Foundation Trust , Salford,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6995-3713","authenticated-orcid":false,"given":"Nikolaos","family":"Marketos","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Sciences and Department of Rheumatology, Link\u00f6ping University , Link\u00f6ping,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikki","family":"Wong","sequence":"additional","affiliation":[{"name":"Renal and Vascular Inflammation Section, Imperial College London , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Dhaygude","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Royal Preston Hospital , Preston,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvind","family":"Ponnusamy","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Royal Preston Hospital , Preston,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ed","family":"O'Riordan","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Salford Royal Foundation Trust , Salford,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Venning","sequence":"additional","affiliation":[{"name":"Manchester Institute of Nephrology & Transplantation, Manchester Royal Infirmary , Manchester,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1221-0772","authenticated-orcid":false,"given":"M\u00e5rten","family":"Segelmark","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Clinical Sciences, Lund University , Lund,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Morgan","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Queen Elizabeth Hospital , Birmingham,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Jayne","sequence":"additional","affiliation":[{"name":"Vasculitis Clinic, Addenbrooke\u2019s Hospital , Cambridge,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6703-3745","authenticated-orcid":false,"given":"Patrick","family":"Hamilton","sequence":"additional","affiliation":[{"name":"Manchester Institute of Nephrology & Transplantation, Manchester Royal Infirmary , Manchester,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles D","family":"Pusey","sequence":"additional","affiliation":[{"name":"Renal and Vascular Inflammation Section, Imperial College London , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1532-2390","authenticated-orcid":false,"given":"Louise","family":"Oni","sequence":"additional","affiliation":[{"name":"Department of Paediatric Nephrology, Alder Hey Children's NHS Foundation Trust Hospital , Liverpool,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9255-9092","authenticated-orcid":false,"given":"Alan D","family":"Salama","sequence":"additional","affiliation":[{"name":"UCL Centre for Nephrology, Royal Free Hospital , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,1,25]]},"reference":[{"key":"2025032905210345600_keae030-B1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/BOR.0b013e32835d8e2a","article-title":"Epidemiology of immunoglobulin A vasculitis (Henoch-Schonlein): current state of knowledge","volume":"25","author":"Piram","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"2025032905210345600_keae030-B2","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s004670050707","article-title":"Clinical outcome of Schonlein-Henoch purpura nephritis in children","volume":"13","author":"Sch\u00e4rer","year":"1999","journal-title":"Pediatr Nephrol"},{"key":"2025032905210345600_keae030-B3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1136\/pgmj.72.843.41","article-title":"Vasculitis and rapidly progressive glomerulonephritis in the elderly","volume":"72","author":"Higgins","year":"1996","journal-title":"Postgrad Med J"},{"key":"2025032905210345600_keae030-B4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/MD.0b013e31817c744b","article-title":"Antineutrophil cytoplasmic autoantibody-associated vasculitis in older patients","volume":"87","author":"Chen","year":"2008","journal-title":"Medicine (Baltimore)"},{"key":"2025032905210345600_keae030-B5","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0272-6386(03)00025-8","article-title":"Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study","volume":"41","author":"Booth","year":"2003","journal-title":"Am J Kid Dis"},{"key":"2025032905210345600_keae030-B6","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.2215\/CJN.00480115","article-title":"Outcome and treatment of elderly patients with ANCA-associated vasculitis","volume":"10","author":"Weiner","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025032905210345600_keae030-B7","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1053\/j.ajkd.2006.02.178","article-title":"L., Predictors of outcome in Henoch-Sch\u00f6nlein nephritis in children and adults","volume":"47","author":"Coppo","year":"2006","journal-title":"Am J Kid Dis"},{"key":"2025032905210345600_keae030-B8","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/art.1780400513","article-title":"Henoch-Schonlein purpura in adulthood and childhood: two different expressions of the same syndrome","volume":"40","author":"Blanco","year":"1997","journal-title":"Arthritis Rheum"},{"key":"2025032905210345600_keae030-B9","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1097\/01.ASN.0000013883.99976.22","article-title":"Henoch-Sch\u00f6nlein purpura in adults: outcome and prognostic factors","volume":"13","author":"Pillebout","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"2025032905210345600_keae030-B10","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/qjmed\/hcl034","article-title":"Henoch Sch\u00f6nlein purpura with nephritis in adults: adverse prognostic indicators in a UK population","volume":"99","author":"Shrestha","year":"2006","journal-title":"QJM Int Med J"},{"key":"2025032905210345600_keae030-B11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/1471-2369-14-169","article-title":"Validation of the absolute renal risk of dialysis\/death in adults with IgA nephropathy secondary to Henoch-Schonlein purpura: a monocentric cohort study","volume":"14","author":"Mohey","year":"2013","journal-title":"BMC Nephrol"},{"key":"2025032905210345600_keae030-B12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1136\/annrheumdis-2018-214142","article-title":"Cardiovascular, thromboembolic and renal outcomes in IgA vasculitis (Henoch-Schonlein purpura): a retrospective cohort study using routinely collected primary care data","volume":"78","author":"Tracy","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2025032905210345600_keae030-B13","doi-asserted-by":"crossref","first-page":"e0196955","DOI":"10.1371\/journal.pone.0196955","article-title":"Distinct characteristics and outcomes in elderly-onset IgA vasculitis (Henoch-Schonlein purpura) with nephritis: nationwide cohort study of data from the Japan Renal Biopsy Registry (J-RBR)","volume":"13","author":"Komatsu","year":"2018","journal-title":"PLoS One"},{"key":"2025032905210345600_keae030-B14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill consensus conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2025032905210345600_keae030-B15","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.medici.2016.11.003","article-title":"IgA nephropathy clinicopathologic study following the Oxford classification: progression peculiarities and gender-related differences","volume":"52","author":"Riispere","year":"2016","journal-title":"Medicina (Kaunas)"},{"key":"2025032905210345600_keae030-B16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12882-018-0829-1","article-title":"Gender-related differences in clinicopathological characteristics and renal outcomes of Chinese patients with IgA nephropathy","volume":"19","author":"Deng","year":"2018","journal-title":"BMC Nephrol"},{"key":"2025032905210345600_keae030-B17","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0140-6736(02)11279-7","article-title":"Incidence of Henoch-Schonlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins","volume":"360","author":"Gardner-Medwin","year":"2002","journal-title":"Lancet"},{"key":"2025032905210345600_keae030-B18","doi-asserted-by":"crossref","first-page":"e1002765","DOI":"10.1371\/journal.pgen.1002765","article-title":"Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis","volume":"8","author":"Kiryluk","year":"2012","journal-title":"PLoS Genet"},{"key":"2025032905210345600_keae030-B19","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1681\/ASN.2010101058","article-title":"DRB115 allele is a risk factor for PR3-ANCA disease in African Americans","volume":"22","author":"Cao","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"2025032905210345600_keae030-B20","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1093\/rheumatology\/kex293","article-title":"Global ethnic and geographic differences in the clinical presentations of anti-neutrophil cytoplasm antibody-associated vasculitis","volume":"56","author":"Pearce","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"2025032905210345600_keae030-B21","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/01.ASN.0000054493.04151.80","article-title":"Octogenarians reaching end-stage renal disease: cohort study of decision-making and clinical outcomes","volume":"14","author":"Joly","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"2025032905210345600_keae030-B22","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1136\/jcp.49.11.942","article-title":"Effect of diagnostic delay on disease severity and outcome in glomerulonephritis caused by anti-neutrophil cytoplasmic antibodies","volume":"49","author":"Lal","year":"1996","journal-title":"J Clin Pathol"},{"key":"2025032905210345600_keae030-B23","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.autrev.2015.02.003","article-title":"IgA vasculitis (Henoch-Shonlein purpura) in adults: diagnostic and therapeutic aspects","volume":"14","author":"Audemard-Verger","year":"2015","journal-title":"Autoimmun Rev"},{"key":"2025032905210345600_keae030-B24","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ki.2010.150","article-title":"Addition of cyclophosphamide to steroids provides no benefit compared with steroids alone in treating adult patients with severe Henoch Schonlein Purpura","volume":"78","author":"Pillebout","year":"2010","journal-title":"Kidney Int"},{"key":"2025032905210345600_keae030-B25","first-page":"303","article-title":"Successful treatment of Henoch-Schonlein purpura nephritis with plasma exchange in an adult male","volume":"1","author":"Chaudhary","year":"2008","journal-title":"NDT Plus"},{"key":"2025032905210345600_keae030-B26","doi-asserted-by":"crossref","first-page":"213","DOI":"10.5414\/CNP61213","article-title":"Successful treatment of crescentic glomerulonephritis associated with adult-onset Henoch-Schoenlein purpura by double-filtration plasmapheresis","volume":"61","author":"Chen","year":"2004","journal-title":"Clin Nephrol"},{"key":"2025032905210345600_keae030-B27","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s10067-005-0113-1","article-title":"Plasmapheresis therapy in an elderly patient with rapidly progressive Henoch-Schonlein purpura with disseminated organ involvement","volume":"26","author":"Rech","year":"2007","journal-title":"Clin Rheumatol"},{"key":"2025032905210345600_keae030-B28","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s12026-016-8827-5","article-title":"Rituximab therapy for IgA-vasculitis with nephritis: a case series and review of the literature","volume":"65","author":"Fenoglio","year":"2017","journal-title":"Immunol Res"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae030\/56619404\/keae030.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/2\/690\/56619404\/keae030.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/2\/690\/56619404\/keae030.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T23:26:23Z","timestamp":1743377183000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/2\/690\/7589942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,25]]},"references-count":28,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,1,25]]},"published-print":{"date-parts":[[2025,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae030","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2024,1,25]]}}}